<?xml version="1.0" encoding="UTF-8"?><measure><measureDetails><uuid>40280381-4c18-79df-014c-2e3345ce0c63</uuid><title>Incidence of Potentially-Preventable Venous Thromboembolism</title><shortTitle>VTE-6</shortTitle><emeasureid>114</emeasureid><guid>32cfc834-843a-4f45-b359-8e158eac4396</guid><version>4.0.000</version><nqfid extension="Not Applicable" root="2.16.840.1.113883.3.560.1"/><period calenderYear="true" uuid="40280381-3d27-5493-013d-477b9d1113b6"><startDate>00000101</startDate><stopDate>00001231</stopDate></period><steward id="1.3.6.1.4.1.33895">The Joint Commission</steward><developers><developer id="1.3.6.1.4.1.33895">The Joint Commission</developer></developers><description>This measure assesses the number of patients diagnosed with confirmed VTE during hospitalization (not present at admission) who did not receive VTE prophylaxis between hospital admission and the day before the VTE diagnostic testing order date.</description><copyright>Measure specifications are in the Public Domain.&#xD;
&#xD;
LOINC(R) is a registered trademark of the Regenstrief Institute.&#xD;
&#xD;
This material contains SNOMED Clinical Terms (R) (SNOMED CT[C]) copyright 2004-2014 International Health Terminology Standards Development Organization. All rights reserved.</copyright><disclaimer>These performance measures are not clinical guidelines and do not establish a standard of medical care, and have not been tested for all potential applications. The measures and specifications are provided without warranty.</disclaimer><scoring id="PROPOR">Proportion</scoring><types><type id="OUTCOME">Outcome</type></types><componentMeasures/><itemCount><elementRef dataType="Encounter, Performed" id="a89d2801-e88e-4f3f-b9e2-d8769703c36e" name="Encounter Inpatient" oid="2.16.840.1.113883.3.666.5.307"/></itemCount><stratification>None</stratification><riskAdjustment>None</riskAdjustment><aggregation>None</aggregation><rationale>The concept of "failure to prevent" has generated interest in national health policy organizations to identify evidence-based practice that will improve patient safety in the hospital setting (Wachter et al 2001). The incidence of preventable venous thromboembolism (VTE) among hospitalized patients is overwhelming, and contributes to extended hospital stays, and the rising cost of health care. Zhan 2003, states that "VTE was the second most common medical complication of postoperative patients, the second most common cause of excess length of stay, and the third most common cause of excess mortality and excess charges". According to Arnold, D.M. (2001), preventable VTE is defined as "objectively diagnosed Deep Vein Thrombosis (DVT) or Pulmonary Emboli (PE) that occurred in a setting in which thromboprophylaxis was indicated but was either administered inadequately or not administered at all." In spite of formal guidelines, and recommendations for preventative care, pulmonary embolism is still the most common preventable cause of death among hospitalized patients (Wachter et al, 2001).</rationale><recommendations>Failure to prevent VTE can result in delayed hospital discharge or readmission, increased risk for long-term morbidity from post-thrombotic syndrome, and recurrent thrombosis in the future.</recommendations><improvementNotations>Improvement noted as a decrease in the rate</improvementNotations><references><reference>Arnold DM, Kahn SR, Shrier I. Missed opportunities for prevention of venous thromboembolism: an evaluation of the use of thromboprophylaxis guidelines. Chest. 2001 Dec;120(6):1964-71.</reference><reference>Guyatt, G.H., Akl, E.A., Crowther, M., Gutterman, D., Schunemann, H. Antithromboitic Therapy and Prevention of Thrombosis, 9th edition: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. CHEST 2012; 141(2)(Supp):7S-47S.</reference><reference>Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, Nelson ME, Wells PS, Gould MK, Dentali F, Crowther M, Kahn SR. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(2 Suppl):e419S-94S.</reference><reference>Wachter, R., Shojania KG, Duncan, B.W., McDonald, K.W., et al. Making health care safer: a critical analysis of patient safety practices; evidence report/ technology assessment No 43. Agency for Healthcare Research and Quality. Publication 01-E0582001.2001. Retrieved March 11, 2015 from http://archive.ahrq.gov/clinic/tp/ptsaftp.htm.</reference><reference>Zhan, C., Miller M.R. Excessive length of stay, charges and mortality attributable to medical injures during hospitalization. JAMA 2003; 290:1868-1874.</reference></references><definitions>None</definitions><guidance>CMS recognizes the difficulty in capturing the VTE confirmed concept required in this measure and suggests eligible hospitals participating in the Medicare &amp; Medicaid EHR Incentive Programs consider selecting alternative electronic clinical quality measures (eCQMs) to meet program requirements for meaningful use. If suitable alternatives are unavailable, CMS will accept a 0 denominator submission for the eCQM version only for this measure. &#xD;
&#xD;
The unit of measurement for this measure is an inpatient episode of care. Each distinct hospitalization should be reported, regardless of whether the same patient is admitted for inpatient care more than once during the measurement period. In addition, the eMeasure logic intends to represent events within or surrounding a single occurrence of an inpatient hospitalization.&#xD;
&#xD;
When low dose unfractionated heparin is not administered due to medical reasons, the intended administration route is subcutaneous.</guidance><transmissionFormat>TBD</transmissionFormat><initialPopDescription>Patients age 18 and older discharged from hospital inpatient acute care during the measurement period with a length of stay less than or equal to 120 days with a non-principal diagnosis of venous thromboembolism (VTE). </initialPopDescription><denominatorDescription>Patients who developed VTE confirmed by a diagnostic test during hospitalization.</denominatorDescription><denominatorExclusionsDescription>Patients with comfort measures documented&#xD;
Patients with VTE present at admission&#xD;
Patients with reasons for not administering mechanical and pharmacologic prophylaxis</denominatorExclusionsDescription><numeratorDescription>Patients who received no VTE prophylaxis prior to the VTE diagnostic test order date.</numeratorDescription><numeratorExclusionsDescription>Not Applicable</numeratorExclusionsDescription><denominatorExceptionsDescription>None</denominatorExceptionsDescription><measurePopulationDescription>Not Applicable</measurePopulationDescription><measurePopulationExclusionsDescription>Not Applicable</measurePopulationExclusionsDescription><measureObservationsDescription>Not Applicable</measureObservationsDescription><supplementalData>For every patient evaluated by this measure also identify payer, race, ethnicity and sex.</supplementalData><qualityMeasureSet uuid="40fe1901-3fff-43cc-b942-b46e3d9cbbe2">eMeasure Venous Thromboembolism (eVTE)</qualityMeasureSet>
<finalizedDate value="201503301107-0500"/>
</measureDetails><supplementalDataElements><elementRef id="40280381-3d27-5493-013d-477b9d1113b2" name="Ethnicity"/><elementRef id="40280381-3d27-5493-013d-477b9d1013b0" name="ONC Administrative Sex"/><elementRef id="40280381-3d27-5493-013d-477b9d1113b3" name="Payer"/><elementRef id="40280381-3d27-5493-013d-477b9d1013b1" name="Race"/></supplementalDataElements><riskAdjustmentVariables/><subTreeLookUp><subTree displayName="EncounterInpatient" qdmVariable="true" uuid="808AA157-AE72-4B30-A63F-2EC85B73BD30"><functionalOp displayName="SATISFIES ALL" type="SATISFIES ALL"><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="a89d2801-e88e-4f3f-b9e2-d8769703c36e" type="qdm"/><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="a89d2801-e88e-4f3f-b9e2-d8769703c36e" type="qdm"><attribute attrUUID="9416aeaf-3ae4-45ba-b94f-e22de7f027fa" comparisonValue="120" mode="Less Than Or Equal To" name="length of stay" unit="days"/></elementRef><relationalOp displayName="Ends During" type="EDU"><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="a89d2801-e88e-4f3f-b9e2-d8769703c36e" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3d27-5493-013d-477b9d1113b6" type="qdm"/></relationalOp></functionalOp></subTree><subTree displayName="Occurrence A of $EncounterInpatient" instance="A" instanceOf="808AA157-AE72-4B30-A63F-2EC85B73BD30" qdmVariable="true" uuid="76C46E69-3D1A-4B0E-93C5-CBF9354A2DE5"><functionalOp displayName="SATISFIES ALL" type="SATISFIES ALL"><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="a89d2801-e88e-4f3f-b9e2-d8769703c36e" type="qdm"/><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="a89d2801-e88e-4f3f-b9e2-d8769703c36e" type="qdm"><attribute attrUUID="9416aeaf-3ae4-45ba-b94f-e22de7f027fa" comparisonValue="120" mode="Less Than Or Equal To" name="length of stay" unit="days"/></elementRef><relationalOp displayName="Ends During" type="EDU"><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="a89d2801-e88e-4f3f-b9e2-d8769703c36e" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3d27-5493-013d-477b9d1113b6" type="qdm"/></relationalOp></functionalOp></subTree><subTree displayName="MedicationVTEProphylaxis" qdmVariable="true" uuid="8FCFE9C7-1E0B-41E1-B98A-F26B019E3B3A"><setOp displayName="UNION" type="union"><elementRef displayName="Low Dose Unfractionated Heparin for VTE Prophylaxis : Medication, Administered" id="088c24da-703f-464e-b5fc-420b55e8028e" type="qdm"><attribute attrUUID="3b580b7f-2cb2-464f-8358-1e3100a6f8db" mode="Value Set" name="route" qdmUUID="40280381-3d27-5493-013d-477b9d1213ca"/></elementRef><elementRef displayName="Low Molecular Weight Heparin for VTE Prophylaxis : Medication, Administered" id="40280381-3d27-5493-013d-477b9d1213cf" type="qdm"/><elementRef displayName="Injectable Factor Xa Inhibitor for VTE Prophylaxis : Medication, Administered" id="40280381-3d27-5493-013d-477b9d1213d0" type="qdm"/><elementRef displayName="Warfarin : Medication, Administered" id="40280381-3d27-5493-013d-477b9d1213d1" type="qdm"/></setOp></subTree><subTree displayName="DeviceVTEProphylaxis" qdmVariable="true" uuid="1E4A12F7-F7C9-4F79-A091-EB61EB2FA371"><setOp displayName="UNION" type="union"><elementRef displayName="Intermittent pneumatic compression devices (IPC) : Device, Applied" id="40280381-3d27-5493-013d-477b9d1113c8" type="qdm"/><elementRef displayName="Venous foot pumps (VFP) : Device, Applied" id="40280381-3d27-5493-013d-477b9d1113c7" type="qdm"/><elementRef displayName="Graduated compression stockings (GCS) : Device, Applied" id="40280381-3d27-5493-013d-477b9d1113c6" type="qdm"/></setOp></subTree><subTree displayName="InterventionComfortMeasures" qdmVariable="true" uuid="0A1F7711-9B72-4D85-8CF2-D2BD73EEE295"><setOp displayName="UNION" type="union"><elementRef displayName="Comfort Measures  : Intervention, Order" id="a38a0b35-9b33-4c3d-9005-53a3104b5323" type="qdm"/><elementRef displayName="Comfort Measures  : Intervention, Performed" id="0d34c7ed-0456-4249-ab8a-f0e096c24ade" type="qdm"/></setOp></subTree><subTree displayName="DiagnosisVTE" qdmVariable="true" uuid="4455D3B4-2E8E-44CC-AD86-F1430C07E19C"><setOp displayName="UNION" type="union"><elementRef displayName="Venous Thromboembolism : Diagnosis, Active" id="40280381-3d27-5493-013d-477b9d1113ba" type="qdm"/><elementRef displayName="Obstetrics VTE : Diagnosis, Active" id="40280381-3d27-5493-013d-477b9d1113b9" type="qdm"/></setOp></subTree><subTree displayName="Age GTET 18 at Occ A EncIP" qdmVariable="false" uuid="457E6CD2-64CE-4AD3-9F48-4E17808E7DEE"><functionalOp displayName="Age &gt;= 18 years at" operatorType="Greater Than or Equal To" quantity="18" type="AGE AT" unit="years"><subTreeRef displayName="Occurrence A of EncounterInpatient" id="76C46E69-3D1A-4B0E-93C5-CBF9354A2DE5" type="subTree"/></functionalOp></subTree><subTree displayName="Union of Dx Active VTE Obstetrics VTE Principal starts during Occ A EncIP" qdmVariable="false" uuid="E90C52FF-68DF-43CB-AF78-350D76292A85"><relationalOp displayName="Starts During" type="SDU"><setOp displayName="UNION" type="union"><elementRef displayName="Venous Thromboembolism : Diagnosis, Active" id="40280381-3d27-5493-013d-477b9d1113ba" type="qdm"><attribute attrUUID="9767c4bc-73bf-4388-9a9a-5cec62de8a0e" mode="Value Set" name="ordinality" qdmUUID="6bae20a8-0612-40ba-8990-4a2c5702c6ef"/></elementRef><elementRef displayName="Obstetrics VTE : Diagnosis, Active" id="40280381-3d27-5493-013d-477b9d1113b9" type="qdm"><attribute attrUUID="3c26ded1-1f75-4566-a253-b5ab3e8b9c0e" mode="Value Set" name="ordinality" qdmUUID="6bae20a8-0612-40ba-8990-4a2c5702c6ef"/></elementRef></setOp><subTreeRef displayName="Occurrence A of EncounterInpatient" id="76C46E69-3D1A-4B0E-93C5-CBF9354A2DE5" type="subTree"/></relationalOp></subTree><subTree displayName="Occ A Dx Study Order VTE Dx Test starts during Occ A EncIP" qdmVariable="false" uuid="A48668F1-F196-4418-AA40-1C127A5EE37E"><relationalOp displayName="Starts During" type="SDU"><elementRef displayName="Occurrence A of VTE Diagnostic Test : Diagnostic Study, Order" id="40280381-3d27-5493-013d-4b56311f41ef" type="qdm"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="76C46E69-3D1A-4B0E-93C5-CBF9354A2DE5" type="subTree"/></relationalOp></subTree><subTree displayName="FIRST Occ A Dx Study Perf VTE Dx Test result Confirm starts during OccA Enc" qdmVariable="false" uuid="70FEFA84-7BF1-43D4-9F6E-35ACB0E140B1"><functionalOp displayName="FIRST" type="FIRST"><relationalOp displayName="Starts During" type="SDU"><elementRef displayName="Occurrence A of VTE Diagnostic Test : Diagnostic Study, Performed" id="5ddb09fc-d2b2-409f-96ce-0ecf8aee4814" type="qdm"><attribute attrUUID="2909c9d6-b088-40d2-8073-c4f09a1ae01f" mode="Value Set" name="result" qdmUUID="40280381-3d27-5493-013d-477b9d1213da"/></elementRef><subTreeRef displayName="Occurrence A of EncounterInpatient" id="76C46E69-3D1A-4B0E-93C5-CBF9354A2DE5" type="subTree"/></relationalOp></functionalOp></subTree><subTree displayName="DxVTE variable starts during Occ A EncIP" qdmVariable="false" uuid="68B7FA2C-5788-4053-A205-B391F79D231F"><relationalOp displayName="Starts During" type="SDU"><subTreeRef displayName="DiagnosisVTE" id="4455D3B4-2E8E-44CC-AD86-F1430C07E19C" type="subTree"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="76C46E69-3D1A-4B0E-93C5-CBF9354A2DE5" type="subTree"/></relationalOp></subTree><subTree displayName="Intersection of NoMedVTEProphMedContra SBS OccA Dx Study Order VTE startsdu" qdmVariable="false" uuid="DEC5F150-4FE1-43DC-B553-4A68EF0CC38E"><setOp displayName="INTERSECTION" type="intersection"><relationalOp displayName="Starts Before Start Of" type="SBS"><subTreeRef displayName="NoMedicationVTEProphylaxisMedicalContraindication" id="451F7828-BE54-4AE4-AD83-0979B33F44F9" type="subTree"/><elementRef displayName="Occurrence A of VTE Diagnostic Test : Diagnostic Study, Order" id="40280381-3d27-5493-013d-4b56311f41ef" type="qdm"/></relationalOp><relationalOp displayName="Starts During" type="SDU"><subTreeRef displayName="NoMedicationVTEProphylaxisMedicalContraindication" id="451F7828-BE54-4AE4-AD83-0979B33F44F9" type="subTree"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="76C46E69-3D1A-4B0E-93C5-CBF9354A2DE5" type="subTree"/></relationalOp></setOp></subTree><subTree displayName="Intersection of NoDeviceVTEProphMedContra SBS OccA Dx Study Order VTE start" qdmVariable="false" uuid="30F3799C-F833-44AB-8653-6E2C4D3D536E"><setOp displayName="INTERSECTION" type="intersection"><relationalOp displayName="Starts Before Start Of" type="SBS"><subTreeRef displayName="NoDeviceVTEProphylaxisMedicalContraindication" id="AF5F0B0E-1FEC-402B-99B2-05B536B6E959" type="subTree"/><elementRef displayName="Occurrence A of VTE Diagnostic Test : Diagnostic Study, Order" id="40280381-3d27-5493-013d-4b56311f41ef" type="qdm"/></relationalOp><relationalOp displayName="Starts During" type="SDU"><subTreeRef displayName="NoDeviceVTEProphylaxisMedicalContraindication" id="AF5F0B0E-1FEC-402B-99B2-05B536B6E959" type="subTree"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="76C46E69-3D1A-4B0E-93C5-CBF9354A2DE5" type="subTree"/></relationalOp></setOp></subTree><subTree displayName="InterventionComfortMsrs starts during Occ A EncIP" qdmVariable="false" uuid="4853DDF4-5951-4468-8451-41A5848F59AC"><relationalOp displayName="Starts During" type="SDU"><subTreeRef displayName="InterventionComfortMeasures" id="0A1F7711-9B72-4D85-8CF2-D2BD73EEE295" type="subTree"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="76C46E69-3D1A-4B0E-93C5-CBF9354A2DE5" type="subTree"/></relationalOp></subTree><subTree displayName="Occurrence A of $MedicationVTEProphylaxis" instance="A" instanceOf="8FCFE9C7-1E0B-41E1-B98A-F26B019E3B3A" qdmVariable="true" uuid="24F917FD-2983-4DA7-80B4-A0FB31A57DD2"><setOp displayName="UNION" type="union"><elementRef displayName="Low Dose Unfractionated Heparin for VTE Prophylaxis : Medication, Administered" id="088c24da-703f-464e-b5fc-420b55e8028e" type="qdm"><attribute attrUUID="3b580b7f-2cb2-464f-8358-1e3100a6f8db" mode="Value Set" name="route" qdmUUID="40280381-3d27-5493-013d-477b9d1213ca"/></elementRef><elementRef displayName="Low Molecular Weight Heparin for VTE Prophylaxis : Medication, Administered" id="40280381-3d27-5493-013d-477b9d1213cf" type="qdm"/><elementRef displayName="Injectable Factor Xa Inhibitor for VTE Prophylaxis : Medication, Administered" id="40280381-3d27-5493-013d-477b9d1213d0" type="qdm"/><elementRef displayName="Warfarin : Medication, Administered" id="40280381-3d27-5493-013d-477b9d1213d1" type="qdm"/></setOp></subTree><subTree displayName="Occurrence A of $DeviceVTEProphylaxis" instance="A" instanceOf="1E4A12F7-F7C9-4F79-A091-EB61EB2FA371" qdmVariable="true" uuid="77485FA6-C19D-4B0B-9015-5D041DDEBB60"><setOp displayName="UNION" type="union"><elementRef displayName="Intermittent pneumatic compression devices (IPC) : Device, Applied" id="40280381-3d27-5493-013d-477b9d1113c8" type="qdm"/><elementRef displayName="Venous foot pumps (VFP) : Device, Applied" id="40280381-3d27-5493-013d-477b9d1113c7" type="qdm"/><elementRef displayName="Graduated compression stockings (GCS) : Device, Applied" id="40280381-3d27-5493-013d-477b9d1113c6" type="qdm"/></setOp></subTree><subTree displayName="Occ A MedVTEProph starts during Occ A EncIP" qdmVariable="false" uuid="9BA6904C-DE97-4C7F-A2DA-37CB6D0521AC"><relationalOp displayName="Starts During" type="SDU"><subTreeRef displayName="Occurrence A of MedicationVTEProphylaxis" id="24F917FD-2983-4DA7-80B4-A0FB31A57DD2" type="subTree"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="76C46E69-3D1A-4B0E-93C5-CBF9354A2DE5" type="subTree"/></relationalOp></subTree><subTree displayName="Occ A Med Adm Oral Factor Xa GTET 1 d SBS Occ A Dx Study Order VTE Dx Test" qdmVariable="false" uuid="9ED394C6-260C-4B8E-839A-B458F19C18FD"><relationalOp displayName="&gt;= 1 days Starts Before Start Of" operatorType="Greater Than or Equal To" quantity="1" type="SBS" unit="days"><elementRef displayName="Occurrence A of Oral Factor Xa Inhibitor for VTE Prophylaxis or VTE Treatment : Medication, Administered" id="8a0ac0d2-1c70-483c-bff9-1f06e82b0402" type="qdm"/><elementRef displayName="Occurrence A of VTE Diagnostic Test : Diagnostic Study, Order" id="40280381-3d27-5493-013d-4b56311f41ef" type="qdm"/></relationalOp></subTree><subTree displayName="Occ A Med Adm Oral Factor Xa starts during Occ A EncIP" qdmVariable="false" uuid="59D5BD67-41FD-42CB-A02F-A39023DC6841"><relationalOp displayName="Starts During" type="SDU"><elementRef displayName="Occurrence A of Oral Factor Xa Inhibitor for VTE Prophylaxis or VTE Treatment : Medication, Administered" id="8a0ac0d2-1c70-483c-bff9-1f06e82b0402" type="qdm"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="76C46E69-3D1A-4B0E-93C5-CBF9354A2DE5" type="subTree"/></relationalOp></subTree><subTree displayName="Occ A DeviceVTEProph GTET 1 d SBS Occ A Dx Study Order VTE Dx Test" qdmVariable="false" uuid="4107FE97-BC8D-4ADE-927E-291D4ABBE781"><relationalOp displayName="&gt;= 1 days Starts Before Start Of" operatorType="Greater Than or Equal To" quantity="1" type="SBS" unit="days"><subTreeRef displayName="Occurrence A of DeviceVTEProphylaxis" id="77485FA6-C19D-4B0B-9015-5D041DDEBB60" type="subTree"/><elementRef displayName="Occurrence A of VTE Diagnostic Test : Diagnostic Study, Order" id="40280381-3d27-5493-013d-4b56311f41ef" type="qdm"/></relationalOp></subTree><subTree displayName="Occ A DeviceVTEProph starts during Occ A EncIP" qdmVariable="false" uuid="B1F3AC19-503C-4AEA-9181-405BA2EA3786"><relationalOp displayName="Starts During" type="SDU"><subTreeRef displayName="Occurrence A of DeviceVTEProphylaxis" id="77485FA6-C19D-4B0B-9015-5D041DDEBB60" type="subTree"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="76C46E69-3D1A-4B0E-93C5-CBF9354A2DE5" type="subTree"/></relationalOp></subTree><subTree displayName="Occ A MedVTEProph GTET 1 d SBS Occ A Dx Study Order VTE Dx Test" qdmVariable="false" uuid="8877633B-0DED-4861-A933-8CE19D78A24B"><relationalOp displayName="&gt;= 1 days Starts Before Start Of" operatorType="Greater Than or Equal To" quantity="1" type="SBS" unit="days"><subTreeRef displayName="Occurrence A of MedicationVTEProphylaxis" id="24F917FD-2983-4DA7-80B4-A0FB31A57DD2" type="subTree"/><elementRef displayName="Occurrence A of VTE Diagnostic Test : Diagnostic Study, Order" id="40280381-3d27-5493-013d-4b56311f41ef" type="qdm"/></relationalOp></subTree><subTree displayName="ED Visit LTET 1 h EBOCWS Occ A EncIP" qdmVariable="false" uuid="21E613E9-BA48-40C9-84C8-380B1101FC39"><relationalOp displayName="&lt;= 1 hours Ends Before Or Concurrent With Start Of" operatorType="Less Than or Equal To" quantity="1" type="EBSORECWS" unit="hours"><elementRef displayName="Emergency Department Visit : Encounter, Performed" id="a032b54f-1f5a-455f-88a8-b63e0826d2a5" type="qdm"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="76C46E69-3D1A-4B0E-93C5-CBF9354A2DE5" type="subTree"/></relationalOp></subTree><subTree displayName="InterventionComfortMsrs starts during ED Visit LTET 1h EBOCWS OccA EncIP" qdmVariable="false" uuid="191EA763-A4DC-46E3-99EE-F1763AE10ABB"><relationalOp displayName="Starts During" type="SDU"><subTreeRef displayName="InterventionComfortMeasures" id="0A1F7711-9B72-4D85-8CF2-D2BD73EEE295" type="subTree"/><subTreeRef displayName="ED Visit LTET 1 h EBOCWS Occ A EncIP" id="21E613E9-BA48-40C9-84C8-380B1101FC39" type="subTree"/></relationalOp></subTree><subTree displayName="DxActive VTE Suspected LTET 4d SBS Occ A EncIP" qdmVariable="false" uuid="52CEF444-58FF-4D41-A1E8-AF8AD574F9D6"><relationalOp displayName="&lt;= 4 days Starts Before Start Of" operatorType="Less Than or Equal To" quantity="4" type="SBS" unit="days"><elementRef displayName="VTE Suspected : Diagnosis, Active" id="40280381-3d27-5493-013d-477b9d1213d4" type="qdm"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="76C46E69-3D1A-4B0E-93C5-CBF9354A2DE5" type="subTree"/></relationalOp></subTree><subTree displayName="Union of Dx Active VTE Suspect DxVTE starts during OccA ED Visit LTET 1h" qdmVariable="false" uuid="799344BE-9986-4F61-ABAC-CE07A07740BA"><relationalOp displayName="Starts During" type="SDU"><setOp displayName="UNION" type="union"><elementRef displayName="VTE Suspected : Diagnosis, Active" id="40280381-3d27-5493-013d-477b9d1213d4" type="qdm"/><subTreeRef displayName="DiagnosisVTE" id="4455D3B4-2E8E-44CC-AD86-F1430C07E19C" type="subTree"/></setOp><subTreeRef displayName="ED Visit LTET 1 h EBOCWS Occ A EncIP" id="21E613E9-BA48-40C9-84C8-380B1101FC39" type="subTree"/></relationalOp></subTree><subTree displayName="Union of Dx Active VTE Suspect DxVTE OccA DxStudyOrderVTE LTET 1d SAS EncIP" qdmVariable="false" uuid="934ACCAE-E097-4ECF-8005-B2382FF469EF"><relationalOp displayName="&lt;= 1 days Starts After Start Of" operatorType="Less Than or Equal To" quantity="1" type="SAS" unit="days"><setOp displayName="UNION" type="union"><elementRef displayName="VTE Suspected : Diagnosis, Active" id="40280381-3d27-5493-013d-477b9d1213d4" type="qdm"/><subTreeRef displayName="DiagnosisVTE" id="4455D3B4-2E8E-44CC-AD86-F1430C07E19C" type="subTree"/><elementRef displayName="Occurrence A of VTE Diagnostic Test : Diagnostic Study, Performed" id="5ddb09fc-d2b2-409f-96ce-0ecf8aee4814" type="qdm"/></setOp><subTreeRef displayName="Occurrence A of EncounterInpatient" id="76C46E69-3D1A-4B0E-93C5-CBF9354A2DE5" type="subTree"/></relationalOp></subTree><subTree displayName="NoMedicationVTEProphylaxisMedicalContraindication" qdmVariable="true" uuid="451F7828-BE54-4AE4-AD83-0979B33F44F9"><setOp displayName="UNION" type="union"><elementRef displayName="Low Dose Unfractionated Heparin for VTE Prophylaxis : Medication, Administered" id="088c24da-703f-464e-b5fc-420b55e8028e" type="qdm"><attribute attrUUID="fabd41ee-bbfb-4709-8a87-9f680d76ee8b" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-477b9d1213db"/></elementRef><elementRef displayName="Low Molecular Weight Heparin for VTE Prophylaxis : Medication, Administered" id="40280381-3d27-5493-013d-477b9d1213cf" type="qdm"><attribute attrUUID="d20ad3df-c84b-44e8-a871-4eb06d8442af" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-477b9d1213db"/></elementRef><elementRef displayName="Injectable Factor Xa Inhibitor for VTE Prophylaxis : Medication, Administered" id="40280381-3d27-5493-013d-477b9d1213d0" type="qdm"><attribute attrUUID="7b551520-69c0-46f7-835c-cf01237e016f" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-477b9d1213db"/></elementRef><elementRef displayName="Warfarin : Medication, Administered" id="40280381-3d27-5493-013d-477b9d1213d1" type="qdm"><attribute attrUUID="ccc0dec3-3597-4429-869e-3278dc078b51" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-477b9d1213db"/></elementRef><elementRef displayName="Unfractionated Heparin for VTE prophylaxis ingredient specific : Medication, Order" id="50187080-816d-4c15-b273-98c46628d35e" type="qdm"><attribute attrUUID="4bcda577-c643-4c99-92fd-bc2203536e07" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-477b9d1213db"/></elementRef><elementRef displayName="Low Molecular Weight Heparin for VTE prophylaxis ingredient specific : Medication, Order" id="908c18cf-ce78-42aa-a1e5-e352c647042c" type="qdm"><attribute attrUUID="f705d974-7a6f-4bfc-8b4e-6081d39fe4d2" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-477b9d1213db"/></elementRef><elementRef displayName="Injectable factor Xa inhibitor for VTE prophylaxis ingredient specific : Medication, Order" id="8c9d3492-e523-4f58-8174-7e48463cd1ef" type="qdm"><attribute attrUUID="1ab3499c-bf0d-475e-ba87-32bf3b1aaa9a" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-477b9d1213db"/></elementRef><elementRef displayName="Warfarin-only ingredient specific : Medication, Order" id="70b35a30-7171-40f4-8451-d816478d957b" type="qdm"><attribute attrUUID="457d749b-9bc1-4459-a3e2-72e018894e27" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-477b9d1213db"/></elementRef></setOp></subTree><subTree displayName="NoDeviceVTEProphylaxisMedicalContraindication" qdmVariable="true" uuid="AF5F0B0E-1FEC-402B-99B2-05B536B6E959"><setOp displayName="UNION" type="union"><elementRef displayName="Intermittent pneumatic compression devices (IPC) : Device, Applied" id="40280381-3d27-5493-013d-477b9d1113c8" type="qdm"><attribute attrUUID="45f0a629-70fa-4d09-9649-6243454032a0" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-477b9d1213db"/></elementRef><elementRef displayName="Venous foot pumps (VFP) : Device, Applied" id="40280381-3d27-5493-013d-477b9d1113c7" type="qdm"><attribute attrUUID="132213c6-1c93-4da9-9e47-402a505f99bf" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-477b9d1213db"/></elementRef><elementRef displayName="Graduated compression stockings (GCS) : Device, Applied" id="40280381-3d27-5493-013d-477b9d1113c6" type="qdm"><attribute attrUUID="170ab1de-b423-494c-8ceb-0c9f1c42dbcd" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-477b9d1213db"/></elementRef><elementRef displayName="Intermittent pneumatic compression devices (IPC) : Device, Order" id="6cde4823-7cc8-424b-8c29-ffbbe3f65e3d" type="qdm"><attribute attrUUID="39cbf9c3-d46a-4b9d-a23f-0a021a4053fd" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-477b9d1213db"/></elementRef><elementRef displayName="Venous foot pumps (VFP) : Device, Order" id="77d3fb70-fed9-4f83-b980-327170bbe1a6" type="qdm"><attribute attrUUID="3085a13a-7aef-48d7-8a47-2657374c2e70" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-477b9d1213db"/></elementRef><elementRef displayName="Graduated compression stockings (GCS) : Device, Order" id="20c114fb-ae5c-43bd-a71a-1510504c2730" type="qdm"><attribute attrUUID="4dc4dbc4-c105-48e6-bc99-99429959d2de" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-477b9d1213db"/></elementRef></setOp></subTree><subTree displayName="NoMedicationDeviceVTEProphylaxisPatientRefusal" qdmVariable="true" uuid="4DD1A719-B0EA-4EE5-877F-522CFDD6433B"><setOp displayName="UNION" type="union"><elementRef displayName="Low Dose Unfractionated Heparin for VTE Prophylaxis : Medication, Administered" id="088c24da-703f-464e-b5fc-420b55e8028e" type="qdm"><attribute attrUUID="61c3fb83-b8f0-45ee-8fbd-611b661627f4" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-477b9d1213d3"/></elementRef><elementRef displayName="Low Molecular Weight Heparin for VTE Prophylaxis : Medication, Administered" id="40280381-3d27-5493-013d-477b9d1213cf" type="qdm"><attribute attrUUID="b4dd1b96-bd2f-42c1-9cc3-d7adf7c7d772" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-477b9d1213d3"/></elementRef><elementRef displayName="Injectable Factor Xa Inhibitor for VTE Prophylaxis : Medication, Administered" id="40280381-3d27-5493-013d-477b9d1213d0" type="qdm"><attribute attrUUID="5d9244c4-4f8d-49ad-9dd0-da770b4381f6" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-477b9d1213d3"/></elementRef><elementRef displayName="Warfarin : Medication, Administered" id="40280381-3d27-5493-013d-477b9d1213d1" type="qdm"><attribute attrUUID="4cc6f8b3-fef0-42c6-8bb4-4c4a511a4244" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-477b9d1213d3"/></elementRef><elementRef displayName="Unfractionated Heparin for VTE prophylaxis ingredient specific : Medication, Order" id="50187080-816d-4c15-b273-98c46628d35e" type="qdm"><attribute attrUUID="910b6639-e843-4ea4-82bc-4df86c501f7b" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-477b9d1213d3"/></elementRef><elementRef displayName="Low Molecular Weight Heparin for VTE prophylaxis ingredient specific : Medication, Order" id="908c18cf-ce78-42aa-a1e5-e352c647042c" type="qdm"><attribute attrUUID="244c97d6-5775-497b-a5cd-0262e2d6e5d0" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-477b9d1213d3"/></elementRef><elementRef displayName="Injectable factor Xa inhibitor for VTE prophylaxis ingredient specific : Medication, Order" id="8c9d3492-e523-4f58-8174-7e48463cd1ef" type="qdm"><attribute attrUUID="0f416222-846b-4180-8fe3-f7eadc094b00" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-477b9d1213d3"/></elementRef><elementRef displayName="Warfarin-only ingredient specific : Medication, Order" id="70b35a30-7171-40f4-8451-d816478d957b" type="qdm"><attribute attrUUID="19398ae0-5e9d-4e57-ba1b-618fcd0c0061" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-477b9d1213d3"/></elementRef><elementRef displayName="Intermittent pneumatic compression devices (IPC) : Device, Applied" id="40280381-3d27-5493-013d-477b9d1113c8" type="qdm"><attribute attrUUID="2eb2b4b5-af88-43b7-aaf3-6ea9756eccdb" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-477b9d1213d3"/></elementRef><elementRef displayName="Venous foot pumps (VFP) : Device, Applied" id="40280381-3d27-5493-013d-477b9d1113c7" type="qdm"><attribute attrUUID="d5edff6d-d71f-4676-839d-c99ec3703c9c" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-477b9d1213d3"/></elementRef><elementRef displayName="Graduated compression stockings (GCS) : Device, Applied" id="40280381-3d27-5493-013d-477b9d1113c6" type="qdm"><attribute attrUUID="a69b2d37-b7d4-4e19-89e2-e21296ac0c31" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-477b9d1213d3"/></elementRef><elementRef displayName="Intermittent pneumatic compression devices (IPC) : Device, Order" id="6cde4823-7cc8-424b-8c29-ffbbe3f65e3d" type="qdm"><attribute attrUUID="775a9885-6516-4d9a-8d89-9e741951d994" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-477b9d1213d3"/></elementRef><elementRef displayName="Venous foot pumps (VFP) : Device, Order" id="77d3fb70-fed9-4f83-b980-327170bbe1a6" type="qdm"><attribute attrUUID="1e0965fb-83c8-45e5-b17c-9ceb38909e55" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-477b9d1213d3"/></elementRef><elementRef displayName="Graduated compression stockings (GCS) : Device, Order" id="20c114fb-ae5c-43bd-a71a-1510504c2730" type="qdm"><attribute attrUUID="25139963-2210-46b8-adc0-3e4357498c86" mode="Value Set" name="negation rationale" qdmUUID="40280381-3d27-5493-013d-477b9d1213d3"/></elementRef></setOp></subTree><subTree displayName="NoMedVTEProphMedContra variable starts during ED Visit LTET 1h EBOCWS OccA" qdmVariable="false" uuid="DE90228F-0964-4555-AB53-F4CF44C4981A"><relationalOp displayName="Starts During" type="SDU"><subTreeRef displayName="NoMedicationVTEProphylaxisMedicalContraindication" id="451F7828-BE54-4AE4-AD83-0979B33F44F9" type="subTree"/><subTreeRef displayName="ED Visit LTET 1 h EBOCWS Occ A EncIP" id="21E613E9-BA48-40C9-84C8-380B1101FC39" type="subTree"/></relationalOp></subTree><subTree displayName="NoDeviceVTEProphMedContra variable starts during ED Visit LTET 1h EBOCWS Oc" qdmVariable="false" uuid="B488544D-61A8-49BD-A7EC-F035202D4CEE"><relationalOp displayName="Starts During" type="SDU"><subTreeRef displayName="NoDeviceVTEProphylaxisMedicalContraindication" id="AF5F0B0E-1FEC-402B-99B2-05B536B6E959" type="subTree"/><subTreeRef displayName="ED Visit LTET 1 h EBOCWS Occ A EncIP" id="21E613E9-BA48-40C9-84C8-380B1101FC39" type="subTree"/></relationalOp></subTree><subTree displayName="NoMedDeviceVTEProphPatRefusal starts during ED Visit LTET 1h EBOCWS OccA En" qdmVariable="false" uuid="B203338F-09F1-45B6-B066-F68F5C7C4F61"><relationalOp displayName="Starts During" type="SDU"><subTreeRef displayName="NoMedicationDeviceVTEProphylaxisPatientRefusal" id="4DD1A719-B0EA-4EE5-877F-522CFDD6433B" type="subTree"/><subTreeRef displayName="ED Visit LTET 1 h EBOCWS Occ A EncIP" id="21E613E9-BA48-40C9-84C8-380B1101FC39" type="subTree"/></relationalOp></subTree><subTree displayName="Intersection of NoMedDeviceVTEProphPatRefusal SBS Occ A DxStudyOrder VTE st" qdmVariable="false" uuid="E828797E-A2F1-40A0-8E01-606D43363301"><setOp displayName="INTERSECTION" type="intersection"><relationalOp displayName="Starts Before Start Of" type="SBS"><subTreeRef displayName="NoMedicationDeviceVTEProphylaxisPatientRefusal" id="4DD1A719-B0EA-4EE5-877F-522CFDD6433B" type="subTree"/><elementRef displayName="Occurrence A of VTE Diagnostic Test : Diagnostic Study, Order" id="40280381-3d27-5493-013d-4b56311f41ef" type="qdm"/></relationalOp><relationalOp displayName="Starts During" type="SDU"><subTreeRef displayName="NoMedicationDeviceVTEProphylaxisPatientRefusal" id="4DD1A719-B0EA-4EE5-877F-522CFDD6433B" type="subTree"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="76C46E69-3D1A-4B0E-93C5-CBF9354A2DE5" type="subTree"/></relationalOp></setOp></subTree><subTree displayName="Intersection of Med Adm Direct Thrombin Inhibitor SBS DxStudy starts during" qdmVariable="false" uuid="29104C98-C1EA-4C49-88B9-D9682D31BDB3"><setOp displayName="INTERSECTION" type="intersection"><relationalOp displayName="Starts Before Start Of" type="SBS"><elementRef displayName="Direct Thrombin Inhibitor : Medication, Administered" id="e39f12c3-b437-446a-989e-0926bea210b9" type="qdm"/><elementRef displayName="Occurrence A of VTE Diagnostic Test : Diagnostic Study, Order" id="40280381-3d27-5493-013d-4b56311f41ef" type="qdm"/></relationalOp><relationalOp displayName="Starts During" type="SDU"><elementRef displayName="Direct Thrombin Inhibitor : Medication, Administered" id="e39f12c3-b437-446a-989e-0926bea210b9" type="qdm"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="76C46E69-3D1A-4B0E-93C5-CBF9354A2DE5" type="subTree"/></relationalOp></setOp></subTree><subTree displayName="Intersection of Med Adm Glycoprotein IIb IIIa Inhibitors SBS DxStudy starts" qdmVariable="false" uuid="2C64CDA0-3CF5-499A-857D-F602C2ED4016"><setOp displayName="INTERSECTION" type="intersection"><relationalOp displayName="Starts Before Start Of" type="SBS"><elementRef displayName="Glycoprotein IIb/IIIa Inhibitors : Medication, Administered" id="8c057e4b-f5a4-4668-ae2b-f2568c0550e9" type="qdm"/><elementRef displayName="Occurrence A of VTE Diagnostic Test : Diagnostic Study, Order" id="40280381-3d27-5493-013d-4b56311f41ef" type="qdm"/></relationalOp><relationalOp displayName="Starts During" type="SDU"><elementRef displayName="Glycoprotein IIb/IIIa Inhibitors : Medication, Administered" id="8c057e4b-f5a4-4668-ae2b-f2568c0550e9" type="qdm"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="76C46E69-3D1A-4B0E-93C5-CBF9354A2DE5" type="subTree"/></relationalOp></setOp></subTree></subTreeLookUp><measureGrouping><group sequence="1"><clause displayName="Initial Population 2" type="initialPopulation" uuid="EC8AF5B6-2E3E-4907-9D5C-E57995EFC724"><logicalOp displayName="AND" type="and"><subTreeRef displayName="Age GTET 18 at Occ A EncIP" id="457E6CD2-64CE-4AD3-9F48-4E17808E7DEE" type="subTree"/><logicalOp displayName="AND NOT" type="andNot"><subTreeRef displayName="Union of Dx Active VTE Obstetrics VTE Principal starts during Occ A EncIP" id="E90C52FF-68DF-43CB-AF78-350D76292A85" type="subTree"/></logicalOp><subTreeRef displayName="DxVTE variable starts during Occ A EncIP" id="68B7FA2C-5788-4053-A205-B391F79D231F" type="subTree"><comment displayName="comment" type="comment"/></subTreeRef></logicalOp></clause><clause displayName="Denominator 1" type="denominator" uuid="FB3A0698-36CF-4D6F-914E-630D6662F58A"><logicalOp displayName="AND" type="and"><comment displayName="comment" type="comment"/><subTreeRef displayName="Occ A Dx Study Order VTE Dx Test starts during Occ A EncIP" id="A48668F1-F196-4418-AA40-1C127A5EE37E" type="subTree"/><subTreeRef displayName="FIRST Occ A Dx Study Perf VTE Dx Test result Confirm starts during OccA Enc" id="70FEFA84-7BF1-43D4-9F6E-35ACB0E140B1" type="subTree"/></logicalOp></clause><clause displayName="Denominator Exclusions 2" type="denominatorExclusions" uuid="104F6477-EA45-40CF-92B4-D8AFDAE91D01"><logicalOp displayName="OR" type="or"><comment displayName="comment" type="comment"/><subTreeRef displayName="InterventionComfortMsrs starts during Occ A EncIP" id="4853DDF4-5951-4468-8451-41A5848F59AC" type="subTree"><comment displayName="comment" type="comment">Comfort measures</comment></subTreeRef><subTreeRef displayName="InterventionComfortMsrs starts during ED Visit LTET 1h EBOCWS OccA EncIP" id="191EA763-A4DC-46E3-99EE-F1763AE10ABB" type="subTree"/><subTreeRef displayName="DxActive VTE Suspected LTET 4d SBS Occ A EncIP" id="52CEF444-58FF-4D41-A1E8-AF8AD574F9D6" type="subTree"><comment displayName="comment" type="comment">VTE present at admission</comment></subTreeRef><subTreeRef displayName="Union of Dx Active VTE Suspect DxVTE starts during OccA ED Visit LTET 1h" id="799344BE-9986-4F61-ABAC-CE07A07740BA" type="subTree"/><subTreeRef displayName="Union of Dx Active VTE Suspect DxVTE OccA DxStudyOrderVTE LTET 1d SAS EncIP" id="934ACCAE-E097-4ECF-8005-B2382FF469EF" type="subTree"/><subTreeRef displayName="Intersection of Med Adm Direct Thrombin Inhibitor SBS DxStudy starts during" id="29104C98-C1EA-4C49-88B9-D9682D31BDB3" type="subTree"><comment displayName="comment" type="comment">Reasons for not administering mechanical and pharmacologic prophylaxis</comment></subTreeRef><subTreeRef displayName="Intersection of Med Adm Glycoprotein IIb IIIa Inhibitors SBS DxStudy starts" id="2C64CDA0-3CF5-499A-857D-F602C2ED4016" type="subTree"/><logicalOp displayName="AND" type="and"><subTreeRef displayName="NoMedVTEProphMedContra variable starts during ED Visit LTET 1h EBOCWS OccA" id="DE90228F-0964-4555-AB53-F4CF44C4981A" type="subTree"/><subTreeRef displayName="NoDeviceVTEProphMedContra variable starts during ED Visit LTET 1h EBOCWS Oc" id="B488544D-61A8-49BD-A7EC-F035202D4CEE" type="subTree"/></logicalOp><logicalOp displayName="AND" type="and"><subTreeRef displayName="Intersection of NoMedVTEProphMedContra SBS OccA Dx Study Order VTE startsdu" id="DEC5F150-4FE1-43DC-B553-4A68EF0CC38E" type="subTree"/><subTreeRef displayName="Intersection of NoDeviceVTEProphMedContra SBS OccA Dx Study Order VTE start" id="30F3799C-F833-44AB-8653-6E2C4D3D536E" type="subTree"/></logicalOp><subTreeRef displayName="NoMedDeviceVTEProphPatRefusal starts during ED Visit LTET 1h EBOCWS OccA En" id="B203338F-09F1-45B6-B066-F68F5C7C4F61" type="subTree"/><subTreeRef displayName="Intersection of NoMedDeviceVTEProphPatRefusal SBS Occ A DxStudyOrder VTE st" id="E828797E-A2F1-40A0-8E01-606D43363301" type="subTree"><comment displayName="comment" type="comment"/></subTreeRef></logicalOp></clause><clause displayName="Numerator 1" type="numerator" uuid="A2EB88AE-1CA2-43DD-9881-4AF125E99EF8"><logicalOp displayName="AND" type="and"><logicalOp displayName="AND NOT" type="andNot"><logicalOp displayName="AND" type="and"><comment displayName="comment" type="comment"/><subTreeRef displayName="Occ A MedVTEProph GTET 1 d SBS Occ A Dx Study Order VTE Dx Test" id="8877633B-0DED-4861-A933-8CE19D78A24B" type="subTree"/><subTreeRef displayName="Occ A MedVTEProph starts during Occ A EncIP" id="9BA6904C-DE97-4C7F-A2DA-37CB6D0521AC" type="subTree"/></logicalOp><logicalOp displayName="AND" type="and"><subTreeRef displayName="Occ A Med Adm Oral Factor Xa GTET 1 d SBS Occ A Dx Study Order VTE Dx Test" id="9ED394C6-260C-4B8E-839A-B458F19C18FD" type="subTree"/><subTreeRef displayName="Occ A Med Adm Oral Factor Xa starts during Occ A EncIP" id="59D5BD67-41FD-42CB-A02F-A39023DC6841" type="subTree"/></logicalOp><logicalOp displayName="AND" type="and"><subTreeRef displayName="Occ A DeviceVTEProph GTET 1 d SBS Occ A Dx Study Order VTE Dx Test" id="4107FE97-BC8D-4ADE-927E-291D4ABBE781" type="subTree"/><subTreeRef displayName="Occ A DeviceVTEProph starts during Occ A EncIP" id="B1F3AC19-503C-4AEA-9181-405BA2EA3786" type="subTree"><comment displayName="comment" type="comment"/></subTreeRef></logicalOp></logicalOp></logicalOp></clause><clause displayName="numeratorExclusions" type="numeratorExclusions" uuid="389fa9a1-4882-43fe-9c05-a1f6528eeb3b"><logicalOp displayName="AND" type="and"/></clause><clause displayName="denominatorExceptions" type="denominatorExceptions" uuid="15631cf4-0214-4062-bb1c-be7dee147c12"><logicalOp displayName="AND" type="and"/></clause><clause displayName="stratum" type="stratum" uuid="01bb9a59-79b7-49c2-a7e4-66007e4d8df1"/></group></measureGrouping><elementLookUp><qdm datatype="Patient Characteristic Birthdate" id="c776b634-69a4-47a9-b21c-f0155f2dd097" name="Birthdate" oid="21112-8" suppDataElement="false" taxonomy="SNOMED-CT" uuid="c776b634-69a4-47a9-b21c-f0155f2dd097" version="1.0"/><qdm datatype="Intervention, Order" id="a38a0b35-9b33-4c3d-9005-53a3104b5323" name="Comfort Measures " oid="1.3.6.1.4.1.33895.1.3.0.45" suppDataElement="false" taxonomy="SNOMEDCT" uuid="a38a0b35-9b33-4c3d-9005-53a3104b5323" version="1.0"/><qdm datatype="Intervention, Performed" id="0d34c7ed-0456-4249-ab8a-f0e096c24ade" name="Comfort Measures " oid="1.3.6.1.4.1.33895.1.3.0.45" suppDataElement="false" taxonomy="SNOMEDCT" uuid="0d34c7ed-0456-4249-ab8a-f0e096c24ade" version="1.0"/><qdm datatype="Medication, Administered" id="e39f12c3-b437-446a-989e-0926bea210b9" name="Direct Thrombin Inhibitor" oid="2.16.840.1.113883.3.117.1.7.1.205" suppDataElement="false" taxonomy="RXNORM" uuid="e39f12c3-b437-446a-989e-0926bea210b9" version="1.0"/><qdm datatype="Encounter, Performed" id="a032b54f-1f5a-455f-88a8-b63e0826d2a5" name="Emergency Department Visit" oid="2.16.840.1.113883.3.117.1.7.1.292" suppDataElement="false" taxonomy="SNOMEDCT" uuid="a032b54f-1f5a-455f-88a8-b63e0826d2a5" version="1.0"/><qdm datatype="Encounter, Performed" id="a89d2801-e88e-4f3f-b9e2-d8769703c36e" name="Encounter Inpatient" oid="2.16.840.1.113883.3.666.5.307" suppDataElement="false" taxonomy="SNOMEDCT" uuid="a89d2801-e88e-4f3f-b9e2-d8769703c36e" version="1.0"/><qdm codeSystemName="CDC NCHS" datatype="Patient Characteristic Ethnicity" id="40280381-3d27-5493-013d-477b9d1113b2" name="Ethnicity" oid="2.16.840.1.114222.4.11.837" suppDataElement="true" taxonomy="CDCREC" uuid="40280381-3d27-5493-013d-477b9d1113b2" version="1"/><qdm datatype="Patient Characteristic Expired" id="fe1af69c-f4dc-40ae-a937-790cee8d0f33" name="Expired" oid="419099009" suppDataElement="false" taxonomy="SNOMED-CT" uuid="fe1af69c-f4dc-40ae-a937-790cee8d0f33" version="1.0"/><qdm datatype="Medication, Administered" id="8c057e4b-f5a4-4668-ae2b-f2568c0550e9" name="Glycoprotein IIb/IIIa Inhibitors" oid="2.16.840.1.113762.1.4.1045.41" suppDataElement="false" taxonomy="RXNORM" uuid="8c057e4b-f5a4-4668-ae2b-f2568c0550e9" version="1.0"/><qdm codeSystemName="Joint Commission" datatype="Device, Applied" id="40280381-3d27-5493-013d-477b9d1113c6" name="Graduated compression stockings (GCS)" oid="2.16.840.1.113883.3.117.1.7.1.256" suppDataElement="false" taxonomy="SNOMEDCT" uuid="40280381-3d27-5493-013d-477b9d1113c6" version="1"/><qdm datatype="Device, Order" id="20c114fb-ae5c-43bd-a71a-1510504c2730" name="Graduated compression stockings (GCS)" oid="2.16.840.1.113883.3.117.1.7.1.256" suppDataElement="false" taxonomy="SNOMEDCT" uuid="20c114fb-ae5c-43bd-a71a-1510504c2730" version="1.0"/><qdm codeSystemName="Joint Commission" datatype="Medication, Administered" id="40280381-3d27-5493-013d-477b9d1213d0" name="Injectable Factor Xa Inhibitor for VTE Prophylaxis" oid="2.16.840.1.113883.3.117.1.7.1.211" suppDataElement="false" taxonomy="RXNORM" uuid="40280381-3d27-5493-013d-477b9d1213d0" version="1"/><qdm datatype="Medication, Order" id="8c9d3492-e523-4f58-8174-7e48463cd1ef" name="Injectable factor Xa inhibitor for VTE prophylaxis ingredient specific" oid="2.16.840.1.113762.1.4.1021.11" suppDataElement="false" taxonomy="RXNORM" uuid="8c9d3492-e523-4f58-8174-7e48463cd1ef" version="1.0"/><qdm codeSystemName="Joint Commission" datatype="Device, Applied" id="40280381-3d27-5493-013d-477b9d1113c8" name="Intermittent pneumatic compression devices (IPC)" oid="2.16.840.1.113883.3.117.1.7.1.214" suppDataElement="false" taxonomy="SNOMEDCT" uuid="40280381-3d27-5493-013d-477b9d1113c8" version="1"/><qdm datatype="Device, Order" id="6cde4823-7cc8-424b-8c29-ffbbe3f65e3d" name="Intermittent pneumatic compression devices (IPC)" oid="2.16.840.1.113883.3.117.1.7.1.214" suppDataElement="false" taxonomy="SNOMEDCT" uuid="6cde4823-7cc8-424b-8c29-ffbbe3f65e3d" version="1.0"/><qdm datatype="Medication, Administered" id="088c24da-703f-464e-b5fc-420b55e8028e" name="Low Dose Unfractionated Heparin for VTE Prophylaxis" oid="2.16.840.1.113762.1.4.1045.39" suppDataElement="false" taxonomy="RXNORM" uuid="088c24da-703f-464e-b5fc-420b55e8028e" version="1.0"/><qdm codeSystemName="Joint Commission" datatype="Medication, Administered" id="40280381-3d27-5493-013d-477b9d1213cf" name="Low Molecular Weight Heparin for VTE Prophylaxis" oid="2.16.840.1.113883.3.117.1.7.1.219" suppDataElement="false" taxonomy="RXNORM" uuid="40280381-3d27-5493-013d-477b9d1213cf" version="1"/><qdm datatype="Medication, Order" id="908c18cf-ce78-42aa-a1e5-e352c647042c" name="Low Molecular Weight Heparin for VTE prophylaxis ingredient specific" oid="2.16.840.1.113762.1.4.1021.12" suppDataElement="false" taxonomy="RXNORM" uuid="908c18cf-ce78-42aa-a1e5-e352c647042c" version="1.0"/><qdm codeSystemName="National Quality Forum" datatype="Timing Element" id="40280381-3d27-5493-013d-477b9d1113b6" name="Measurement Period" oid="2.16.840.1.113883.3.67.1.101.1.53" suppDataElement="false" taxonomy="NQF" uuid="40280381-3d27-5493-013d-477b9d1113b6" version="1"/><qdm codeSystemName="Joint Commission" datatype="attribute" id="40280381-3d27-5493-013d-477b9d1213db" name="Medical Contraindication" oid="2.16.840.1.113883.3.117.1.7.1.412" suppDataElement="false" taxonomy="SNOMEDCT" uuid="40280381-3d27-5493-013d-477b9d1213db" version="1"/><qdm codeSystemName="Joint Commission" datatype="Diagnosis, Active" id="40280381-3d27-5493-013d-477b9d1113b9" name="Obstetrics VTE" oid="2.16.840.1.113883.3.117.1.7.1.264" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d27-5493-013d-477b9d1113b9" version="1"/><qdm codeSystemName="National Library of Medicine" datatype="Patient Characteristic Sex" id="40280381-3d27-5493-013d-477b9d1013b0" name="ONC Administrative Sex" oid="2.16.840.1.113762.1.4.1" suppDataElement="true" taxonomy="AdministrativeGender" uuid="40280381-3d27-5493-013d-477b9d1013b0" version="1"/><qdm datatype="Medication, Administered" id="8a0ac0d2-1c70-483c-bff9-1f06e82b0402" instance="Occurrence A" name="Oral Factor Xa Inhibitor for VTE Prophylaxis or VTE Treatment" oid="2.16.840.1.113883.3.117.1.7.1.134" suppDataElement="false" taxonomy="RXNORM" uuid="8a0ac0d2-1c70-483c-bff9-1f06e82b0402" version="1.0"/><qdm codeSystemName="Joint Commission" datatype="attribute" id="40280381-3d27-5493-013d-477b9d1213d3" name="Patient Refusal" oid="2.16.840.1.113883.3.117.1.7.1.93" suppDataElement="false" taxonomy="SNOMEDCT" uuid="40280381-3d27-5493-013d-477b9d1213d3" version="1"/><qdm codeSystemName="PHDSC" datatype="Patient Characteristic Payer" id="40280381-3d27-5493-013d-477b9d1113b3" name="Payer" oid="2.16.840.1.114222.4.11.3591" suppDataElement="true" taxonomy="SOP" uuid="40280381-3d27-5493-013d-477b9d1113b3" version="1"/><qdm datatype="attribute" id="6bae20a8-0612-40ba-8990-4a2c5702c6ef" name="Principal" oid="2.16.840.1.113883.3.117.1.7.1.14" suppDataElement="false" taxonomy="SNOMEDCT" uuid="6bae20a8-0612-40ba-8990-4a2c5702c6ef" version="1.0"/><qdm codeSystemName="CDC NCHS" datatype="Patient Characteristic Race" id="40280381-3d27-5493-013d-477b9d1013b1" name="Race" oid="2.16.840.1.114222.4.11.836" suppDataElement="true" taxonomy="CDCREC" uuid="40280381-3d27-5493-013d-477b9d1013b1" version="1"/><qdm codeSystemName="Joint Commission" datatype="attribute" id="40280381-3d27-5493-013d-477b9d1213ca" name="Subcutaneous route" oid="2.16.840.1.113883.3.117.1.7.1.223" suppDataElement="false" taxonomy="SNOMEDCT" uuid="40280381-3d27-5493-013d-477b9d1213ca" version="1"/><qdm datatype="Medication, Order" id="50187080-816d-4c15-b273-98c46628d35e" name="Unfractionated Heparin for VTE prophylaxis ingredient specific" oid="2.16.840.1.113762.1.4.1021.13" suppDataElement="false" taxonomy="RXNORM" uuid="50187080-816d-4c15-b273-98c46628d35e" version="1.0"/><qdm codeSystemName="Joint Commission" datatype="Device, Applied" id="40280381-3d27-5493-013d-477b9d1113c7" name="Venous foot pumps (VFP)" oid="2.16.840.1.113883.3.117.1.7.1.230" suppDataElement="false" taxonomy="SNOMEDCT" uuid="40280381-3d27-5493-013d-477b9d1113c7" version="1"/><qdm datatype="Device, Order" id="77d3fb70-fed9-4f83-b980-327170bbe1a6" name="Venous foot pumps (VFP)" oid="2.16.840.1.113883.3.117.1.7.1.230" suppDataElement="false" taxonomy="SNOMEDCT" uuid="77d3fb70-fed9-4f83-b980-327170bbe1a6" version="1.0"/><qdm codeSystemName="Joint Commission" datatype="Diagnosis, Active" id="40280381-3d27-5493-013d-477b9d1113ba" name="Venous Thromboembolism" oid="2.16.840.1.113883.3.117.1.7.1.279" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d27-5493-013d-477b9d1113ba" version="1"/><qdm codeSystemName="Joint Commission" datatype="attribute" id="40280381-3d27-5493-013d-477b9d1213da" name="VTE Confirmed" oid="2.16.840.1.113883.3.117.1.7.1.407" suppDataElement="false" taxonomy="SNOMEDCT" uuid="40280381-3d27-5493-013d-477b9d1213da" version="1"/><qdm codeSystemName="Joint Commission" datatype="Diagnostic Study, Order" id="40280381-3d27-5493-013d-4b56311f41ef" instance="Occurrence A" name="VTE Diagnostic Test" oid="2.16.840.1.113883.3.117.1.7.1.276" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d27-5493-013d-4b56311f41ef" version="1"/><qdm datatype="Diagnostic Study, Performed" id="5ddb09fc-d2b2-409f-96ce-0ecf8aee4814" instance="Occurrence A" name="VTE Diagnostic Test" oid="2.16.840.1.113883.3.117.1.7.1.276" suppDataElement="false" taxonomy="Grouping" uuid="5ddb09fc-d2b2-409f-96ce-0ecf8aee4814" version="1.0"/><qdm codeSystemName="Joint Commission" datatype="Diagnosis, Active" id="40280381-3d27-5493-013d-477b9d1213d4" name="VTE Suspected" oid="2.16.840.1.113883.3.117.1.7.1.277" suppDataElement="false" taxonomy="SNOMEDCT" uuid="40280381-3d27-5493-013d-477b9d1213d4" version="1"/><qdm codeSystemName="Joint Commission" datatype="Medication, Administered" id="40280381-3d27-5493-013d-477b9d1213d1" name="Warfarin" oid="2.16.840.1.113883.3.117.1.7.1.232" suppDataElement="false" taxonomy="RXNORM" uuid="40280381-3d27-5493-013d-477b9d1213d1" version="1"/><qdm datatype="Medication, Order" id="70b35a30-7171-40f4-8451-d816478d957b" name="Warfarin-only ingredient specific" oid="2.16.840.1.113762.1.4.1021.10" suppDataElement="false" taxonomy="RXNORM" uuid="70b35a30-7171-40f4-8451-d816478d957b" version="1.0"/><qdm datatype="Medication, Administered" id="6285c3c8-7859-479c-8f0e-bd87f122eb74" name="Oral Factor Xa Inhibitor for VTE Prophylaxis or VTE Treatment" oid="2.16.840.1.113883.3.117.1.7.1.134" suppDataElement="false" taxonomy="RXNORM" uuid="6285c3c8-7859-479c-8f0e-bd87f122eb74" version="1.0"/><qdm codeSystemName="Joint Commission" datatype="Diagnostic Study, Order" id="14f514cd-aba1-4f9c-83e9-ae8b7cca62ee" name="VTE Diagnostic Test" oid="2.16.840.1.113883.3.117.1.7.1.276" suppDataElement="false" taxonomy="Grouping" uuid="14f514cd-aba1-4f9c-83e9-ae8b7cca62ee" version="1"/><qdm datatype="Diagnostic Study, Performed" id="0a620bbb-9f9a-4f21-a38a-ad8a9a036995" name="VTE Diagnostic Test" oid="2.16.840.1.113883.3.117.1.7.1.276" suppDataElement="false" taxonomy="Grouping" uuid="0a620bbb-9f9a-4f21-a38a-ad8a9a036995" version="1.0"/></elementLookUp></measure>